Copyright Reports & Markets. All rights reserved.

Global Nonalcoholic Steatohepatitis (NASH) Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Nonalcoholic Steatohepatitis (NASH) Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Obeticholic acid（OCA）
    • 1.4.3 Selonsertib
    • 1.4.4 Emricasan
    • 1.4.5 GR-MD-02
    • 1.4.6 IMM-124E
  • 1.5 Market by Application
    • 1.5.1 Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital Pharmacy
    • 1.5.3 Online Provider
    • 1.5.4 Retail Pharmacy
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Perspective (2015-2026)
  • 2.2 Global Nonalcoholic Steatohepatitis (NASH) Growth Trends by Regions
    • 2.2.1 Nonalcoholic Steatohepatitis (NASH) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Nonalcoholic Steatohepatitis (NASH) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Nonalcoholic Steatohepatitis (NASH) Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Nonalcoholic Steatohepatitis (NASH) Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Nonalcoholic Steatohepatitis (NASH) Players by Market Size
    • 3.1.1 Global Top Nonalcoholic Steatohepatitis (NASH) Players by Revenue (2015-2020)
    • 3.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Nonalcoholic Steatohepatitis (NASH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio
    • 3.2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Nonalcoholic Steatohepatitis (NASH) Revenue in 2019
  • 3.3 Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Area Served
  • 3.4 Key Players Nonalcoholic Steatohepatitis (NASH) Product Solution and Service
  • 3.5 Date of Enter into Nonalcoholic Steatohepatitis (NASH) Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Nonalcoholic Steatohepatitis (NASH) Historic Market Size by Type (2015-2020)
  • 4.2 Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2015-2020)
  • 5.2 Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Nonalcoholic Steatohepatitis (NASH) Market Size (2015-2020)
  • 6.2 Nonalcoholic Steatohepatitis (NASH) Key Players in North America (2019-2020)
  • 6.3 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2015-2020)
  • 6.4 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size (2015-2020)
  • 7.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Europe (2019-2020)
  • 7.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2015-2020)
  • 7.4 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2015-2020)

8 China

  • 8.1 China Nonalcoholic Steatohepatitis (NASH) Market Size (2015-2020)
  • 8.2 Nonalcoholic Steatohepatitis (NASH) Key Players in China (2019-2020)
  • 8.3 China Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2015-2020)
  • 8.4 China Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Nonalcoholic Steatohepatitis (NASH) Market Size (2015-2020)
  • 9.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Japan (2019-2020)
  • 9.3 Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2015-2020)
  • 9.4 Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size (2015-2020)
  • 10.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2015-2020)

11 India

  • 11.1 India Nonalcoholic Steatohepatitis (NASH) Market Size (2015-2020)
  • 11.2 Nonalcoholic Steatohepatitis (NASH) Key Players in India (2019-2020)
  • 11.3 India Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2015-2020)
  • 11.4 India Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size (2015-2020)
  • 12.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2015-2020)
  • 12.4 Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Tobira Therapeutics
    • 13.1.1 Tobira Therapeutics Company Details
    • 13.1.2 Tobira Therapeutics Business Overview
    • 13.1.3 Tobira Therapeutics Nonalcoholic Steatohepatitis (NASH) Introduction
    • 13.1.4 Tobira Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2015-2020))
    • 13.1.5 Tobira Therapeutics Recent Development
  • 13.2 Cadila Healthcare
    • 13.2.1 Cadila Healthcare Company Details
    • 13.2.2 Cadila Healthcare Business Overview
    • 13.2.3 Cadila Healthcare Nonalcoholic Steatohepatitis (NASH) Introduction
    • 13.2.4 Cadila Healthcare Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2015-2020)
    • 13.2.5 Cadila Healthcare Recent Development
  • 13.3 Conatus Pharmaceuticals
    • 13.3.1 Conatus Pharmaceuticals Company Details
    • 13.3.2 Conatus Pharmaceuticals Business Overview
    • 13.3.3 Conatus Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
    • 13.3.4 Conatus Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2015-2020)
    • 13.3.5 Conatus Pharmaceuticals Recent Development
  • 13.4 Galmed Pharmaceuticals
    • 13.4.1 Galmed Pharmaceuticals Company Details
    • 13.4.2 Galmed Pharmaceuticals Business Overview
    • 13.4.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
    • 13.4.4 Galmed Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2015-2020)
    • 13.4.5 Galmed Pharmaceuticals Recent Development
  • 13.5 Gemphire Therapeutics
    • 13.5.1 Gemphire Therapeutics Company Details
    • 13.5.2 Gemphire Therapeutics Business Overview
    • 13.5.3 Gemphire Therapeutics Nonalcoholic Steatohepatitis (NASH) Introduction
    • 13.5.4 Gemphire Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2015-2020)
    • 13.5.5 Gemphire Therapeutics Recent Development
  • 13.6 Genfit
    • 13.6.1 Genfit Company Details
    • 13.6.2 Genfit Business Overview
    • 13.6.3 Genfit Nonalcoholic Steatohepatitis (NASH) Introduction
    • 13.6.4 Genfit Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2015-2020)
    • 13.6.5 Genfit Recent Development
  • 13.7 Gilead Sciences
    • 13.7.1 Gilead Sciences Company Details
    • 13.7.2 Gilead Sciences Business Overview
    • 13.7.3 Gilead Sciences Nonalcoholic Steatohepatitis (NASH) Introduction
    • 13.7.4 Gilead Sciences Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2015-2020)
    • 13.7.5 Gilead Sciences Recent Development
  • 13.8 Intercept Pharmaceuticals
    • 13.8.1 Intercept Pharmaceuticals Company Details
    • 13.8.2 Intercept Pharmaceuticals Business Overview
    • 13.8.3 Intercept Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
    • 13.8.4 Intercept Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2015-2020)
    • 13.8.5 Intercept Pharmaceuticals Recent Development
  • 13.9 Novartis International
    • 13.9.1 Novartis International Company Details
    • 13.9.2 Novartis International Business Overview
    • 13.9.3 Novartis International Nonalcoholic Steatohepatitis (NASH) Introduction
    • 13.9.4 Novartis International Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2015-2020)
    • 13.9.5 Novartis International Recent Development
  • 13.10 Takeda
    • 13.10.1 Takeda Company Details
    • 13.10.2 Takeda Business Overview
    • 13.10.3 Takeda Nonalcoholic Steatohepatitis (NASH) Introduction
    • 13.10.4 Takeda Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2015-2020)
    • 13.10.5 Takeda Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Nonalcoholic Steatohepatitis (NASH) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nonalcoholic Steatohepatitis (NASH) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Tobira Therapeutics
    Cadila Healthcare
    Conatus Pharmaceuticals
    Galmed Pharmaceuticals
    Gemphire Therapeutics
    Genfit
    Gilead Sciences
    Intercept Pharmaceuticals
    Novartis International
    Takeda

    Market segment by Type, the product can be split into
    Obeticholic acid（OCA）
    Selonsertib
    Emricasan
    GR-MD-02
    IMM-124E
    Market segment by Application, split into
    Hospital Pharmacy
    Online Provider
    Retail Pharmacy

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now